NS-035

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameNS-035
Drug Alias NameNS-035
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWalker-Warburg Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNippon Shinyaku Co Ltd
Inactive CompaniesN/A
Active IndicationsWalker-Warburg Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A